RxDoctor Payments Data

Aaron Kime, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Saint Helena, CANPI 1841635869

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (56.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Surgical Specialties Corporation (US), Inc. (dba Corza Medical) at 47.7% of the total. Reporting peaked in 2023 at $7,170 and has fallen 80.9% since, to $1,372 in 2025.

$13,164in general payments, 2019–2025

Across 107 payments — averaging $123.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Surgical Specialties Corporation (US), Inc. (dba Corza Medical)$6K
  • Atricure, Inc.$4K
  • Edwards Lifesciences$1K
  • Baxter Healthcare$310
  • Shockwave Medical, Inc$229
  • Abbott$195
  • plus $1K from 15 others
$10,000in research payments, 2019–2025

Across 1 payment — averaging $10,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pulse Biosciences, Inc.$10K

What the payments were for

  • Consulting fees$7,38856%
  • Travel & lodging$1771%
  • Food & beverage$5,60043%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,164 in reported general payments places this provider in the 70th percentile of 546 thoracic surgery (cardiothoracic vascular surgery) providers in California.

See all thoracic surgery (cardiothoracic vascular surgery) providers in California →

Medicare billing

Part B allowed, 2024
$270,202
Medicare patients
275
Services billed
586

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Saint Helena

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →